Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 20;141(46):18551-18559.
doi: 10.1021/jacs.9b09385. Epub 2019 Nov 6.

Stereodivergent, Chemoenzymatic Synthesis of Azaphilone Natural Products

Affiliations

Stereodivergent, Chemoenzymatic Synthesis of Azaphilone Natural Products

Joshua B Pyser et al. J Am Chem Soc. .

Abstract

Selective access to a targeted isomer is often critical in the synthesis of biologically active molecules. Whereas small-molecule reagents and catalysts often act with anticipated site- and stereoselectivity, this predictability does not extend to enzymes. Further, the lack of access to catalysts that provide complementary selectivity creates a challenge in the application of biocatalysis in synthesis. Here, we report an approach for accessing biocatalysts with complementary selectivity that is orthogonal to protein engineering. Through the use of a sequence similarity network (SSN), a number of sequences were selected, and the corresponding biocatalysts were evaluated for reactivity and selectivity. With a number of biocatalysts identified that operate with complementary site- and stereoselectivity, these catalysts were employed in the stereodivergent, chemoenzymatic synthesis of azaphilone natural products. Specifically, the first syntheses of trichoflectin, deflectin-1a, and lunatoic acid A were achieved. In addition, chemoenzymatic syntheses of these azaphilones supplied enantioenriched material for reassignment of the absolute configuration of trichoflectin and deflectin-1a based on optical rotation, CD spectra, and X-ray crystallography.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1.
Figure 1.
A) Approaches to enabling biocatalytic stereodiversity. B) Biologically active azaphilone natural products feature both the R- and S-configuration at the C7 stereocenter.,, Biocatalytic oxidative dearomatization gives access to either enantiomer via AzaH or AfoD mediated oxidation.
Figure 2.
Figure 2.
A) Sequence similarity network (SSN) of FAD-dependent monooxygenases (Pfam01494) using a sequence alignment score of 110. B) Results of expression, activity with model substrate S9 or S14**, site- and stereoselectivity of enzymes chosen from the SSN in panel A. *FDMO4 demonstrated <10% conversion by UPLC with substrate S9. C) Selected clusters from a more stringent SSN generated with an alignment score of 150 and corresponding analysis of the multisequence alignment of each cluster.
Figure 3.
Figure 3.
A) Retrosynthetic analysis of the natural product trichoflectin (17). B) Total synthesis of (S)- and (R)-trichoflectin. C) Calculated and measured CD data for (S)- and (R)-trichoflectin. D) Total synthesis of (S)-deflectin-1a (24). E) Calculated and measured CD data for (S)- and (R)-deflectin-1a. *NADPH recycling system: G6P (2 equiv), NADP(+) (0.4 equiv), G6PDH (1 U/mL).
Figure 4.
Figure 4.
A) Retrosynthetic analysis of azaphilone natural product lunatoic acid A (25). B) Total synthesis of lunatoic acid A (25). C) Calculated and measured CD data for lunatoic acid A methyl ester* (28). *NADPH recycling system: G6P (2 equiv), NADP(+) (0.4 equiv), G6PDH (1 U/mL)

References

    1. Devine PN; Howard RM; Kumar R; Thompson MP; Truppo MD; Turner NJ, Extending the application of biocatalysis to meet the challenges of drug development. Nat. Rev. Chem 2018, 2, 409–421.
    1. France SP; Aleku GA; Sharma M; Mangas-Sanchez J; Howard RM; Steflik J; Kumar R; Adams RW; Slabu I; Crook R; Grogan G; Wallace TW; Turner NJ, Biocatalytic Routes to Enantiomerically Enriched Dibenz[c,e]azepines. Angew. Chem. Int. Ed 2017, 56, 15589–15593. - PubMed
    1. Savile CK; Janey JM; Mundorff EC; Moore JC; Tam S; Jarvis WR; Colbeck JC; Krebber A; Fleitz FJ; Brands J; Devine PN; Huisman GW; Hughes GJ, Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture. Science 2010, 329, 305–309. - PubMed
    1. Bajaj P; Sreenilayam G; Tyagi V; Fasan R, Gram-Scale Synthesis of Chiral Cyclopropane-Containing Drugs and Drug Precursors with Engineered Myoglobin Catalysts Featuring Complementary Stereoselectivity. Angew. Chem. Int. Ed 2016, 55, 16110–16114. - PMC - PubMed
    1. Loskot SA; Romney DK; Arnold FH; Stoltz BM, Enantioselective Total Synthesis of Nigelladine A via Late-Stage C–H Oxidation Enabled by an Engineered P450 Enzyme. J. Am. Chem. Soc 2017, 139, 10196–10199. - PMC - PubMed

Publication types

MeSH terms